Cargando…
A porcine in-vivo model of acute pulmonary embolism
Acute pulmonary embolism (PE) is the third most common cardiovascular cause of death after acute myocardial infarction and stroke. Patients are, however, often under-treated due to the risks associated with systemic thrombolysis and surgical embolectomy. Novel pharmacological and catheter-based trea...
Autores principales: | Schultz, Jacob, Andersen, Asger, Gade, Inger Lise, Ringgaard, Steffen, Kjaergaard, Benedict, Nielsen-Kudsk, Jens Erik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5798692/ https://www.ncbi.nlm.nih.gov/pubmed/28971735 http://dx.doi.org/10.1177/2045893217738217 |
Ejemplares similares
-
Putative Biomarkers for Acute Pulmonary Embolism in Exhaled Breath Condensate
por: Gade, Inger Lise, et al.
Publicado: (2021) -
Levosimendan, milrinone, and dobutamine in experimental acute pulmonary embolism
por: Lyhne, Mads D., et al.
Publicado: (2021) -
Pulmonary vasodilation in acute pulmonary embolism – a systematic review
por: Lyhne, Mads Dam, et al.
Publicado: (2020) -
Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial
por: Andersen, Asger, et al.
Publicado: (2021) -
Levosimendan in pulmonary hypertension and right heart
failure
por: Hansen, Mona Sahlholdt, et al.
Publicado: (2018)